DiaSorin SpA Earnings Estimate
DiaSorin SpA Earnings per Share Projection vs Actual
About DiaSorin SpA Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of DiaSorin SpA earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current DiaSorin SpA estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as DiaSorin SpA fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company was founded in 1968 and is headquartered in Saluggia, Italy. DIASORIN SPA operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 3350 people.
Currently Active Assets on Macroaxis
Other Information on Investing in DiaSorin Pink Sheet
DiaSorin SpA financial ratios help investors to determine whether DiaSorin Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DiaSorin with respect to the benefits of owning DiaSorin SpA security.